ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
6.52
0.06
(0.93%)
Closed February 27 12:00AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
6.52
Bid
6.50
Ask
6.55
Volume
1,130,547
6.44 Day's Range 6.56
3.13 52 Week Range 6.885
Market Cap
Previous Close
6.46
Open
6.44
Last Trade
5
@
6.54
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
479,201
Shares Outstanding
466,378,771
Dividend Yield
-
PE Ratio
-693.62
Earnings Per Share (EPS)
-0.01
Revenue
117.07M
Net Profit
-4.37M

About Tuas Limited

Sector
Communications Services, Nec
Industry
Communications Services, Nec
Website
Headquarters
Sydney, New South Wales, Aus
Founded
-
Tuas Limited is listed in the Communications Services sector of the Australian Stock Exchange with ticker TUA. The last closing price for Tuas was AUD6.46. Over the last year, Tuas shares have traded in a share price range of AUD 3.13 to AUD 6.885.

Tuas currently has 466,378,771 shares outstanding. The market capitalization of Tuas is AUD3.01 billion. Tuas has a price to earnings ratio (PE ratio) of -693.62.

TUA Latest News

No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.35-5.094614264926.876.8856.384139136.57393646DE
40.396.362153344216.136.8856.014707306.6181196DE
121.0920.0736648255.436.8855.314792016.26396655DE
262.3556.35491606714.176.8854.084868765.43073248DE
523.38107.6433121023.146.8853.134527484.77302795DE
1564.755269.405099151.7656.8851.0552653953.51643976DE
2606.0212040.56.8850.473934662.00779823DE

TUA - Frequently Asked Questions (FAQ)

What is the current Tuas share price?
The current share price of Tuas is AUD 6.52
How many Tuas shares are in issue?
Tuas has 466,378,771 shares in issue
What is the market cap of Tuas?
The market capitalisation of Tuas is AUD 3.01B
What is the 1 year trading range for Tuas share price?
Tuas has traded in the range of AUD 3.13 to AUD 6.885 during the past year
What is the PE ratio of Tuas?
The price to earnings ratio of Tuas is -693.62
What is the cash to sales ratio of Tuas?
The cash to sales ratio of Tuas is 25.98
What is the reporting currency for Tuas?
Tuas reports financial results in SGD
What is the latest annual turnover for Tuas?
The latest annual turnover of Tuas is SGD 117.07M
What is the latest annual profit for Tuas?
The latest annual profit of Tuas is SGD -4.37M
What is the registered address of Tuas?
The registered address for Tuas is SUITE 49, 61-65 GLENCOE STREET, SUTHERLAND, SYDNEY, NEW SOUTH WALES, 2232
What is the Tuas website address?
The website address for Tuas is www.tuas.com.au
Which industry sector does Tuas operate in?
Tuas operates in the COMMUNICATIONS SERVICES, NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SPAOSpacetalk Ltd
AUD 0.024
(2,300.00%)
66.08k
5EA5E Advanced Materials Inc
AUD 0.865
(1,563.46%)
12.56k
WWGWiseway Group Limited
AUD 0.205
(51.85%)
734.24k
WNRWingara Ag Ltd
AUD 0.007
(40.00%)
320k
WBEWhitebark Energy Limited
AUD 0.007
(40.00%)
310.99k
PIMOPinnacle Minerals Ltd
AUD 0.006
(-57.14%)
216.7k
EDEEden Innovations Ltd
AUD 0.001
(-50.00%)
250.37k
EXLOElixinol Wellness Limited
AUD 0.002
(-50.00%)
948.27k
ASEOAstute Metals NL
AUD 0.005
(-50.00%)
14.8k
SPXOASpenda Ltd
AUD 0.002
(-50.00%)
518.62k
SGQSt George Mining Ltd
AUD 0.0215
(-34.85%)
111.98M
RLLRapid Lithium Ltd
AUD 0.004
(0.00%)
45.98M
SYASayona Mining Limited
AUD 0.0215
(0.00%)
44.16M
SITSite Group International Ltd
AUD 0.001
(-33.33%)
33.8M
RDNRaiden Resources Limited
AUD 0.0055
(-8.33%)
31.34M

Discussion

View Full Feed
maddyandboomer maddyandboomer 40 seconds ago
Table 3A shows more than half billion issued to Phillipe in last FY...guessing we will see more
AXXA
pos_stock_hoarder pos_stock_hoarder 56 seconds ago
Cheers!
gladeshawk gladeshawk 1 minute ago
AIRI>>>>Suggest keeping on your watch lists. With new orders backlog now over $250 Million. Ad to run on CNBC. Just a FYI. HAWK
AIRI
BEIJING BILL BEIJING BILL 1 minute ago
The chart is churning nicely this week ... Setting up for March.

Buy the dips and sell the rips.

It's coming
ADIA
XMaster2023 XMaster2023 1 minute ago
For equivalency between Flaskworks and the manual manufacturing method, would NWBO not only need to show a robust immune response within a given period? This is an extremely short duration.
NWBO
maddyandboomer maddyandboomer 2 minutes ago
Phillipe current conversion rate is .00026
AXXA
Golden Cross Golden Cross 2 minutes ago
$NIXX Looking for a strong day as we squeeze the shorts. Zero shares to borrow now!
https://investorshub.advfn.com/uimage/uploads/2025/2/27/hketrNIXX-CTB.png
NIXX
maddyandboomer maddyandboomer 2 minutes ago
1. You don't sell Cds into market

A. You sign a convertible note with a discounted price (i.e.duanne phillipe had a 35 discount) usually lowest pps over previous 20 days b/c you gave company cash.

B. After a year, one can convert for free trading shares assuming company
AXXA
PinkPennies PinkPennies 2 minutes ago
QNRX radar nice news https://ih.advfn.com/stock-market/NASDAQ/quoin-pharmaceuticals-QNRX/stock-news/95526874/quoin-pharmaceuticals-announces-highly-positive
QNRX
wadegarret wadegarret 2 minutes ago
COHR/LITE/ANET- All went down 32% for no reason, and

after blowout reports and guidance. This is why Warren Buffet wants no part of tech stocks. They can crash out of nowhere.
PSIX
TommyJ7651 TommyJ7651 3 minutes ago
I noticed Steve Lines had exercised 335 042 rights (resulting in 335 042 common shares) as recently as 25 February. Always nice to see him commit to more shares since he is in charge of the entire EA process. The key point here is that even though it might sound like a small amount of shares it migh
FFMGF
gladeshawk gladeshawk 3 minutes ago
AIRI>>>Undervalued, imho. With new orders backlog now over $250 Million. Suggest keeping on your watch lists. Just a FYI. HAWK
AIRI
threebabiesbusy threebabiesbusy 3 minutes ago
Posted 15 mins ago….On February 27, 2025, NLS Pharmaceutics announced new preclinical data for AEX-2, a non-sulfonamide dual orexin receptor agonist, highlighting its potential for treating narcolepsy and related neurological disorders. The findings suggest AEX-2 offers a safer and more targeted alt
NLSP
threebabiesbusy threebabiesbusy 3 minutes ago
On February 27, 2025, NLS Pharmaceutics announced new preclinical data for AEX-2, a non-sulfonamide dual orexin receptor agonist, highlighting its potential for treating narcolepsy and related neurological disorders. The findings suggest AEX-2 offers a safer and more targeted alternative to existing
NLSP
dewophile dewophile 3 minutes ago
EDP-323

DDI study just listed yesterday

https://clinicaltrials.gov/study/NCT06847464?term=rsv%20enanta&aggFilters=status:rec&rank=3
ENTA
work-n-hard work-n-hard 3 minutes ago
ULY: .90 picking up steam
ULY
MartinLutherKing MartinLutherKing 3 minutes ago
Premarket $2.75.. 3Million market cap Where do you want it to go… Its a sabotage, Cant you see management are all fraud artists
https://www.transcodetherapeutics.com/leadership.html
RNAZ
BullNBear52 BullNBear52 3 minutes ago
~~COMPX 2/27/2025~~~~~~~

Previous Close

19075.26 +48.88

19252 BullNBear52
19194 SSKILLZ1
COMP
JMCK6193 JMCK6193 3 minutes ago
You're a 🤡 
FOXO
PinkPennies PinkPennies 3 minutes ago
QNRX radar news https://ih.advfn.com/stock-market/NASDAQ/quoin-pharmaceuticals-QNRX/stock-news/95526874/quoin-pharmaceuticals-announces-highly-positive
QNRX
Doubledown75 Doubledown75 4 minutes ago
Gonna be a fun day;)
SPY
PinkPennies PinkPennies 4 minutes ago
QNRX radar news https://ih.advfn.com/stock-market/NASDAQ/quoin-pharmaceuticals-QNRX/stock-news/95526874/quoin-pharmaceuticals-announces-highly-positive
QNRX
gladeshawk gladeshawk 4 minutes ago
AIRI>>>With total backlog going over $250 Million pps has company undervalued, imho. Suggest keeping on your watch lists. Just a FYI. HAWK
AIRI
MightyX MightyX 4 minutes ago
And yall are already on a first-name basis
TPTW
Ask$lapper Ask$lapper 4 minutes ago
GM LD!!